ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

about

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

P2860

Q21129306-BD0325B7-2524-4440-B204-BFCC6784298E Q37863688-8B8A5466-8120-4336-9D8C-29A766BA8874

P2860

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

Item

http://www.wikidata.org/entity/Q35614635

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@ast

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@en

type

Item

label

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@ast

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@en

prefLabel

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@ast

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@en

P1476

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

@en

P2860

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines

Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth

P304

1675-1681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/1042819031000099625

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Gambacorti-Passerini

Lorena Passoni

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14692518

http://www.w3.org/2001/XMLSchema#string

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

about

P2860

P2860

ALK a novel lymphoma-associated tumor antigen for vaccination strategies.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698